LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 127 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,601 | -44.5% | 28,475 | -33.7% | 0.00% | – |
| Q2 2023 | $60,528 | -27.1% | 42,928 | -20.0% | 0.00% | – |
| Q1 2022 | $83,000 | -50.0% | 53,656 | -20.8% | 0.00% | – |
| Q4 2021 | $166,000 | +1.2% | 67,780 | +4.0% | 0.00% | – |
| Q3 2021 | $164,000 | -65.6% | 65,203 | -61.0% | 0.00% | -100.0% |
| Q2 2021 | $477,000 | +243.2% | 167,396 | -0.6% | 0.00% | – |
| Q1 2020 | $139,000 | -6.1% | 168,433 | +1.2% | 0.00% | – |
| Q4 2019 | $148,000 | -9.2% | 166,508 | 0.0% | 0.00% | – |
| Q3 2019 | $163,000 | – | 166,508 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,935,485 | $41,223,872 | 3.66% |
| Raffles Associates | 1,587,739 | $1,873,532 | 2.48% |
| Defender Capital, LLC. | 5,184,510 | $6,117,722 | 2.22% |
| Prescott General Partners LLC | 1,851,851 | $2,185,184 | 0.14% |
| DCF Advisers, LLC | 82,751 | $97,646 | 0.05% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $63,450 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 781,766 | $922,484 | 0.02% |
| Fort Sheridan Advisors LLC | 83,931 | $99,039 | 0.02% |
| MAI Capital Management | 954,688 | $1,126,532 | 0.02% |
| Piscataqua Savings Bank | 12,499 | $14,623 | 0.01% |